IRIS Accounts Production v23.2.0.158 07570635 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh075706352022-03-31075706352023-03-31075706352022-04-012023-03-31075706352021-03-31075706352021-04-012022-03-31075706352022-03-3107570635ns10:Originalns15:EnglandWales2022-04-012023-03-3107570635ns14:PoundSterlingns10:Original2022-04-012023-03-3107570635ns10:Originalns10:Director12022-04-012023-03-3107570635ns10:Original2022-04-012023-03-3107570635ns10:Original2023-03-3107570635ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3107570635ns10:Originalns10:SmallEntities2022-04-012023-03-3107570635ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3107570635ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3107570635ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3107570635ns10:Originalns10:FullAccounts2022-04-012023-03-3107570635ns10:Original12022-04-012023-03-3107570635ns10:Originalns10:Director22022-04-012023-03-3107570635ns10:Originalns10:RegisteredOffice2022-04-012023-03-3107570635ns10:Original2022-03-3107570635ns10:Originalns5:CurrentFinancialInstruments2023-03-3107570635ns10:Originalns5:CurrentFinancialInstruments2022-03-3107570635ns5:ShareCapitalns10:Original2023-03-3107570635ns5:ShareCapitalns10:Original2022-03-3107570635ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3107570635ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3107570635ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-04-012023-03-3107570635ns10:Originalns5:ComputerEquipment2022-04-012023-03-3107570635ns10:Original2021-04-012022-03-3107570635ns10:Originalns5:NetGoodwill2022-03-3107570635ns10:Originalns5:NetGoodwill2023-03-3107570635ns10:Originalns5:NetGoodwill2022-03-3107570635ns10:Originalns5:ComputerEquipment2022-03-3107570635ns10:Originalns5:ComputerEquipment2023-03-3107570635ns10:Originalns5:ComputerEquipment2022-03-3107570635ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3107570635ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-31
REGISTERED NUMBER: 07570635 (England and Wales)















Unaudited Financial Statements

for the Year Ended 31 March 2023

for

Birmingham and Solihull ENT Limited

Birmingham and Solihull ENT Limited (Registered number: 07570635)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Birmingham and Solihull ENT Limited

Company Information
for the Year Ended 31 March 2023







DIRECTORS: M A Simmons
Mrs G P Simmons





REGISTERED OFFICE: 26 Hill Village Road
Sutton Coldfield
West Midlands
B75 5BA





REGISTERED NUMBER: 07570635 (England and Wales)





ACCOUNTANTS: Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP

Birmingham and Solihull ENT Limited (Registered number: 07570635)

Balance Sheet
31 March 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 5,667 6,727
5,667 6,727

CURRENT ASSETS
Debtors 6 31,847 26,967
Cash at bank 229,526 200,429
261,373 227,396
CREDITORS
Amounts falling due within one
year

7

37,771

36,518
NET CURRENT ASSETS 223,602 190,878
TOTAL ASSETS LESS CURRENT
LIABILITIES

229,269

197,605

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 229,259 197,595
SHAREHOLDERS' FUNDS 229,269 197,605

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Birmingham and Solihull ENT Limited (Registered number: 07570635)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 November 2023 and were signed on its behalf by:





M A Simmons - Director


Birmingham and Solihull ENT Limited (Registered number: 07570635)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Birmingham and Solihull ENT Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents trading income accrued during the period shown by these financial statements.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% Reducing Balance

Pension costs and other post-retirement benefits
The company contributes to a defined contribution pension scheme. Contributions payable to the pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2022 - 4 ) .

Birmingham and Solihull ENT Limited (Registered number: 07570635)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2022
and 31 March 2023 71,000
AMORTISATION
At 1 April 2022
and 31 March 2023 71,000
NET BOOK VALUE
At 31 March 2023 -
At 31 March 2022 -

5. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2022 18,276
Additions 829
At 31 March 2023 19,105
DEPRECIATION
At 1 April 2022 11,549
Charge for year 1,889
At 31 March 2023 13,438
NET BOOK VALUE
At 31 March 2023 5,667
At 31 March 2022 6,727

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 18,515 14,856
Other debtors 13,332 12,111
31,847 26,967

Birmingham and Solihull ENT Limited (Registered number: 07570635)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 34,361 31,787
Other creditors 3,410 4,731
37,771 36,518